STAT

Get ready for STAT Madness 2018

STAT Madness is fundamentally a celebration of science. It starts Monday.

What does great biomedical science look like? Is it an advance in cancer therapy? A device that helps people recover from injury faster? Or, is it an inexpensive tool that gives developing nations a chance to fight crippling disease?

Great bioscience looks like all of this, and those examples are among the nearly 150 entries you sent us for STAT Madness, our yearly contest to find the next best innovations in health and medicine.

Starting Monday, we’ll seed a single-elimination bracket of 64 entries that will give us a crowd-voted favorite. (Click for last year’s

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Brain Biopsies On ‘Vulnerable’ Patients At Mount Sinai Set Off Alarm Bells At FDA, Documents Show
A STAT Investigation: Brain biopsies on "vulnerable" patients at Mount Sinai set off alarm bells at FDA, documents show.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About CVS And Humira Biosimilars, Schumer’s Broken Insulin Promise, And More
New prescriptions for biosimilar versions of Humira, one of the best-selling drugs in the U.S., surged to 36% from just 5% during the first week of April.

Related Books & Audiobooks